Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chianese

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptidesRebecca C Harris, Kimberly A Chianese-Bullock, Gina R Petroni, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Amrita Sarkar, et al.
Cancer Immunology Research|August 20, 2021
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer PatientsAmanda M Lulu, Kara L Cummings, Erin D Jeffery, et al.
International Journal of Cancer|September 4, 2021
A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancerKevin T Lynch, Gabriella C Squeo, William J Kane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trialCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccineElizabeth M H Woodson, Kimberly A Chianese-Bullock, Catherine J Wiernasz, et al.
BMC Cancer|December 6, 2008
The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccinesDonna H Deacon, Kevin T Hogan, Erin M Swanson, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 2, 2011
The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptidesRebecca C Harris, Kimberly A Chianese-Bullock, Gina R Petroni, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2Kimberly A Chianese-Bullock, Elizabeth M H Woodson, Huimin Tao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2026
Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trialEmily K Ninmer, Hong Zhu, Amrita Sarkar, et al.
Cancer Immunology Research|August 20, 2021
Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer PatientsAmanda M Lulu, Kara L Cummings, Erin D Jeffery, et al.
International Journal of Cancer|September 4, 2021
A pilot trial of vaccination with Carcinoembryonic antigen and Her2/neu peptides in advanced colorectal cancerKevin T Lynch, Gabriella C Squeo, William J Kane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trialCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Assessment of the toxicities of systemic low-dose interleukin-2 administered in conjunction with a melanoma peptide vaccineElizabeth M H Woodson, Kimberly A Chianese-Bullock, Catherine J Wiernasz, et al.
BMC Cancer|December 6, 2008
The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccinesDonna H Deacon, Kevin T Hogan, Erin M Swanson, et al.
Pageof 6